Drug discovery firm Exscientia has claimed a world first after announcing that the first precision engineered drug generated by artificial intelligence (AI) is entering clinical trials.
As access to healthcare professionals (HCPs) declines, the challenges facing sales representatives continue to increase: less time with HCPs, Sunshine Act restrictions, and integration of p
Researchers from a UK university have devised an artificial intelligence (AI)-based system that can detect low glucose levels using an ECG readout without a fingerprick test, in healthy pat